Skip to main content

Kamari Pharma

Ness Ziona, Israel

Kamari Pharma develops innovative treatments for unmet needs and rare diseases in dermatology.

$23.0M raised
Jun 2025
Series A

Top Investors

PontifaxBRM CapitalGIBF

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Kamari Pharma

How much funding has Kamari Pharma raised?
Kamari Pharma has raised $23.0M in total funding. The most recent round was Series A. The last funding was announced in June 2025.
Who are Kamari Pharma's investors?
Kamari Pharma's investors include Pontifax, BRM Capital, GIBF.
Where is Kamari Pharma headquartered?
Kamari Pharma is headquartered in Ness Ziona, Israel.
What does Kamari Pharma do?
Kamari Pharma develops innovative treatments for unmet needs and rare diseases in dermatology.
What stage is Kamari Pharma at?
Kamari Pharma is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Kamari Pharma — Funding & Investors." VCBacked, June 3, 2025, https://www.vcbacked.co/company/kamari-pharma. Accessed June 3, 2026.
APA
VCBacked. (2025). Kamari Pharma — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/kamari-pharma
Wikipedia (cite web)
{{cite web |title=Kamari Pharma — Funding & Investors |url=https://www.vcbacked.co/company/kamari-pharma |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .